[Haematopoietic stem cell donation from minor donor: Respecting laws, assessing fitness, delivering information and good care (SFGM-TC)].
Don de cellules souches hématopoïétiques à partir d’un donneur mineur : cadre réglementaire, information, évaluation de l’aptitude au don et parcours (SFGM-TC).
Don
Donation
Greffe de cellules souches hématopoïétiques
Guidelines
Haematopoietic stem cell transplant
Mineur
Minors
Paediatrics
Recommandations
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
15 May 2024
15 May 2024
Historique:
received:
25
02
2024
revised:
19
03
2024
accepted:
02
04
2024
medline:
17
5
2024
pubmed:
17
5
2024
entrez:
16
5
2024
Statut:
aheadofprint
Résumé
Haematopoietic stem cell collection from paediatric donors is a common and life-saving practice, as evidenced by the fact that there is a growing annual number of cases of transplants from minor donors among SFGM-TC centers over the last decade. Still, medical use of human tissue from a healthy and underage donor requires proper regulations and medical management. The guidelines below aim at underlining the importance of pondering the legal, medical and ethical aspects of using stem cells from healthy paediatric donors and stress out the importance of obtaining informed consent at the time of assessing HLA compatibility. Combined medical and psychological assessments are required before the donation, as well as one month later and one year later to ensure of the child's physical and mental wellbeing. Bone marrow harvest under general anaesthetics remains the preferred method of collection for children. Peripheral blood stem cell collection should only be considered for children who will not require a central venous access for collection. We aim at offering guidelines centered on the healthy child donating stem cells and his/her wellbeing, and these should be regularly reviewed as medical practices evolve.
Identifiants
pubmed: 38755034
pii: S0007-4551(24)00152-8
doi: 10.1016/j.bulcan.2024.04.002
pii:
doi:
Types de publication
English Abstract
Practice Guideline
Langues
fre
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.